Study S001505

Efficacy of Once Weekly Semaglutide in Patients With Type 2 Diabetes: a Non Randomized Clinical Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07732218
Study type: INTERVENTIONAL
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 95
Start: 2022-07-04
Primary completion: 2023-03-30
Lead sponsor: Rehman Medical Institute - RMI
Conditions: Type 2 Diabetes
Interventions: DRUG:Semaglutide (Ozempic®)
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in Glycated hemoglobin [baseline and 16 week]
Changes in Glycated Hemoglobin [Baseline and week 16]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.